Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

Matthew F. Covington, Scott J Sherman, Denise Lewis, Hong Lei, Elizabeth A Krupinski, Phillip H Kuo

Research output: Contribution to journalArticle

4 Citations (Scopus)

Abstract

Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

Original languageEnglish (US)
Article numbere0134457
JournalPLoS One
Volume10
Issue number7
DOIs
StatePublished - Jul 30 2015

Fingerprint

Dopamine Plasma Membrane Transport Proteins
dopamine
transporters
image analysis
Imaging techniques
Diagnostic Imaging
Medication Adherence
Surveys and Questionnaires
ioflupane
Patient Satisfaction
Therapeutics

ASJC Scopus subject areas

  • Agricultural and Biological Sciences(all)
  • Biochemistry, Genetics and Molecular Biology(all)
  • Medicine(all)

Cite this

Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging. / Covington, Matthew F.; Sherman, Scott J; Lewis, Denise; Lei, Hong; Krupinski, Elizabeth A; Kuo, Phillip H.

In: PLoS One, Vol. 10, No. 7, e0134457, 30.07.2015.

Research output: Contribution to journalArticle

@article{d32bc547b52b4acc94b9ca6528e01e68,
title = "Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging",
abstract = "Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46{\%}) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69{\%} of patients. Changes to treatment plan from imaging were reported by 24{\%} of patients. Overall satisfaction with the study and its impact was reported by 70{\%} of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.",
author = "Covington, {Matthew F.} and Sherman, {Scott J} and Denise Lewis and Hong Lei and Krupinski, {Elizabeth A} and Kuo, {Phillip H}",
year = "2015",
month = "7",
day = "30",
doi = "10.1371/journal.pone.0134457",
language = "English (US)",
volume = "10",
journal = "PLoS One",
issn = "1932-6203",
publisher = "Public Library of Science",
number = "7",

}

TY - JOUR

T1 - Patient survey on satisfaction and impact of 123I-ioflupane dopamine transporter imaging

AU - Covington, Matthew F.

AU - Sherman, Scott J

AU - Lewis, Denise

AU - Lei, Hong

AU - Krupinski, Elizabeth A

AU - Kuo, Phillip H

PY - 2015/7/30

Y1 - 2015/7/30

N2 - Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

AB - Patients were surveyed to assess the impact of dopamine transporter imaging on diagnostic confidence, change in treatment plan, effect on medication compliance, and subjective well-being. Surveys were sent to 140 patients who completed dopamine transporter imaging an average of 18 months prior. Sixty-five surveys from patients (46%) were returned. Questions assessed patients' perceived impact of the imaging on their care. Increased diagnostic confidence following imaging was reported by 69% of patients. Changes to treatment plan from imaging were reported by 24% of patients. Overall satisfaction with the study and its impact was reported by 70% of patients. Dopamine transporter imaging increased diagnostic confidence among patients and overall patient satisfaction with the impact of imaging on clinical care was high.

UR - http://www.scopus.com/inward/record.url?scp=84941966191&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84941966191&partnerID=8YFLogxK

U2 - 10.1371/journal.pone.0134457

DO - 10.1371/journal.pone.0134457

M3 - Article

C2 - 26226362

AN - SCOPUS:84941966191

VL - 10

JO - PLoS One

JF - PLoS One

SN - 1932-6203

IS - 7

M1 - e0134457

ER -